Representative Jared Moskowitz (D-Florida) recently bought shares of McKesson Corporation (NYSE:MCK). In a filing disclosed on January 16th, the Representative disclosed that they had bought between $1,001 and $15,000 in McKesson stock on December 2nd. The trade occurred in the Representative’s “MORGAN STANLEY ACTIVE ASSETS (1)” account.
Representative Jared Moskowitz also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Atmos Energy (NYSE:ATO) on 12/2/2025.
- Purchased $1,001 – $15,000 in shares of Public Service Enterprise Group (NYSE:PEG) on 12/2/2025.
- Purchased $1,001 – $15,000 in shares of Southern (NYSE:SO) on 12/2/2025.
- Sold $15,001 – $50,000 in shares of PepsiCo (NASDAQ:PEP) on 12/2/2025.
- Sold $1,001 – $15,000 in shares of PepsiCo (NASDAQ:PEP) on 12/2/2025.
McKesson Price Performance
Shares of NYSE MCK opened at $840.29 on Tuesday. The stock has a market cap of $103.72 billion, a P/E ratio of 26.15, a price-to-earnings-growth ratio of 1.38 and a beta of 0.41. McKesson Corporation has a 1 year low of $570.51 and a 1 year high of $895.58. The firm has a 50-day moving average of $833.09 and a 200 day moving average of $767.73.
McKesson Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, January 2nd. Stockholders of record on Monday, December 1st were given a $0.82 dividend. The ex-dividend date of this dividend was Monday, December 1st. This represents a $3.28 annualized dividend and a dividend yield of 0.4%. McKesson’s dividend payout ratio is currently 10.21%.
Analyst Ratings Changes
MCK has been the subject of a number of recent research reports. Jefferies Financial Group boosted their price objective on shares of McKesson from $820.00 to $900.00 and gave the stock a “buy” rating in a research note on Monday, October 13th. Wells Fargo & Company lifted their price target on McKesson from $816.00 to $914.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Leerink Partners lifted their price objective on McKesson from $785.00 to $850.00 and gave the company an “outperform” rating in a research note on Wednesday, September 24th. Wall Street Zen downgraded shares of McKesson from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Finally, UBS Group boosted their price target on McKesson from $920.00 to $980.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Two analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $895.79.
View Our Latest Report on McKesson
Insider Activity
In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the stock in a transaction on Friday, November 7th. The shares were sold at an average price of $861.63, for a total value of $283,476.27. Following the completion of the sale, the chief accounting officer owned 328 shares in the company, valued at $282,614.64. This trade represents a 50.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Thomas L. Rodgers sold 276 shares of the stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the completion of the transaction, the executive vice president directly owned 2,268 shares in the company, valued at $1,851,096.24. The trade was a 10.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.08% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On McKesson
A number of institutional investors and hedge funds have recently modified their holdings of the stock. Balboa Wealth Partners grew its stake in McKesson by 22.6% in the fourth quarter. Balboa Wealth Partners now owns 1,089 shares of the company’s stock valued at $893,000 after purchasing an additional 201 shares in the last quarter. Dorato Capital Management bought a new stake in shares of McKesson in the fourth quarter valued at about $592,000. Earned Wealth Advisors LLC lifted its holdings in shares of McKesson by 44.9% during the 4th quarter. Earned Wealth Advisors LLC now owns 788 shares of the company’s stock worth $646,000 after acquiring an additional 244 shares during the period. HF Advisory Group LLC grew its holdings in shares of McKesson by 2,069.6% during the fourth quarter. HF Advisory Group LLC now owns 44,910 shares of the company’s stock worth $36,839,000 after purchasing an additional 42,840 shares during the last quarter. Finally, Trust Co. of Vermont increased its holdings in shares of McKesson by 19.6% in the fourth quarter. Trust Co. of Vermont now owns 482 shares of the company’s stock valued at $395,000 after purchasing an additional 79 shares in the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.
About Representative Moskowitz
Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida’s 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.
Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida’s 23rd Congressional District. He declared candidacy for the 2026 election.
Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor’s degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz’s career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.
McKesson Company Profile
McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.
The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.
Read More
- Five stocks we like better than McKesson
- Wall Street Stockpicker Names #1 Stock of 2026
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.
